The Foundation for the National Institutes of Health (FNIH) bestowed the 2nd annual Trailblazer Prize for Clinician-Scientists (Trailblazer Prize) to James Kochenderfer, M.D., of the National Cancer Institute (NCI) in October 2019. Dr. Kochenderfer received the Trailblazer Prize and a $10,000 honorarium for pioneering the development of immunotherapies that leverage chimeric antigen receptor (CAR) T-cells to treat blood cancers. The Trailblazer Prize is made possible by a generous donation from John I. Gallin, M.D., and Elaine Gallin, Ph.D., to the FNIH. The Trailblazer Prize recognizes the outstanding contributions of early career clinician-scientists whose work has the potential to or has led to innovations in patient care and seeks to raise awareness of the critical role the clinician-scientist plays in biomedical research and clinical care. Dr. Kochenderfer is in NCI Surgery Branch, and his tech transfer work is managed by TTC’s Drs. Abritee Dhal and David Lambertson.